Accretion Nutraveda Limited (BOM:544694)

Market Cap	1.44B
Revenue (ttm)	160.49M +216.6%
Net Income	26.13M
EPS	7.19
Shares Out	7.24M
PE Ratio	27.61
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,000
Average Volume	10,050
Open	193.50
Previous Close	193.90
Day's Range	193.00 - 198.50
52-Week Range	129.00 - 208.00
Beta	n/a
RSI	60.59
Earnings Date	n/a

About Accretion Nutraveda

Accretion Nutraveda Limited manufactures and sells ayurvedic and nutraceutical products in India and Internationally. The company specializes in ayurvedic and nutraceutical products including tablets, capsules, oral liquids, oral powders, external preparations, and oils. Its product portfolio includes tablets, such as film-coated and chewable varieties, for applications in liver care, gynecological care, bone and joint health, and respiratory support; capsules, including hard gelatin and HPMC capsules, targeting areas like liver detoxification,...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2021
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544694

Financial Performance

In fiscal year 2025, Accretion Nutraveda's revenue was 160.49 million, an increase of 216.62% compared to the previous year's 50.69 million. Earnings were 26.13 million, an increase of 217.90%.